MEROPENEM - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2025-03-05
- Label type
- Indexing - product concept
- Version
- 6
- Source
- full-release
- Hydrated at
- 2026-06-05 00:25:27
Label at a glance#
ProductMEROPENEM
Active ingredientMEROPENEM
Products#
Every source-derived product name is available through these pages.
- MEROPENEM
- MEROPENEM ANHYDROUS
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MEROPENEM | FV9J3JU8B1 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meropenem | MEROPENEM | Hikma Pharmaceuticals USA Inc. | 8a2a545e-b336-416a-be73-9e0a7ccf6177 | 2026-08-26 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| Meropenem | MEROPENEM | Sagent Pharmaceuticals | e8848f4a-bca9-4978-b0a1-38483fd4d639 | 2026-03-31 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| Meropenem | MEROPENEM | BluePoint Laboratories | ca5f501c-6520-4d09-aae2-4f5db74d468f | 2025-12-12 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| MEROPENEM | MEROPENEM | Savior Lifetec Corporation | 31dd2160-7dbd-51fa-e054-00144ff88e88 | 2025-11-24 | Warnings, Adverse reactions | MEROPENEM MEROPENEM |
| MEROPENEM | MEROPENEM | Sandoz Inc | 0d37e43b-ff8d-495d-b9af-4fd5fce53d56 | 2025-11-14 | Warnings, Adverse reactions | MEROPENEM MEROPENEM |
| Meropenem | MEROPENEM | Qilu Antibiotics Pharmaceutical Co., Ltd. | 1f9591ed-3a6c-422e-b1be-7b3e4fe5bf3c | 2025-09-16 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| Meropenem | MEROPENEM | Civica, Inc. | 35466216-55ed-4836-8cbc-c8aafb079dae | 2025-09-12 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| MEROPENEM | MEROPENEM | Civica, Inc | b0075b72-c3cc-f844-e053-2a95a90a417f | 2025-09-10 | Warnings, Adverse reactions | MEROPENEM MEROPENEM |
| Meropenem | MEROPENEM | BROOKS STERISCIENCE LIMITED | 58e165b7-e230-4459-abf9-06d5ca1dd7b2 | 2025-07-31 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| Meropenem | MEROPENEM | Eugia US LLC | bf1d3433-9e3f-40a0-8bff-c8ceaa8bab7c | 2025-07-16 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| Meropenem | MEROPENEM | BROOKS STERISCIENCE LIMITED | 6902fee1-6022-4145-a79a-4680ad1fb1e8 | 2025-06-26 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| Meropenem | MEROPENEM | Gland Pharma Limited | 4e4e2c0c-df54-4229-ab90-fa671ecedd57 | 2025-06-26 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| Meropenem | MEROPENEM | Amneal Pharmaceuticals LLC | a456013b-b20e-4b29-b2f9-06f18f1ea6bd | 2025-06-09 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| Meropenem | MEROPENEM | Hikma Pharmaceuticals USA Inc. | d54fdbad-ca93-467c-92d7-c1bd88f3bbe3 | 2024-12-31 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| Meropenem | MEROPENEM | Mylan Institutional LLC | f5154b6f-bca8-4f1e-907b-48ea34caf483 | 2024-12-25 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| Meropenem | MEROPENEM | Hospira, Inc. | e9b6555f-20a1-4415-bb80-3d034cfab95b | 2024-11-06 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| Meropenem | MEROPENEM | Hospira, Inc. | 092ebd9b-77a0-4877-afc3-dd8211730f71 | 2024-11-06 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| MEROPENEM | MEROPENEM | Xellia Pharmaceuticals USA LLC | 06d84c55-94ff-46e5-8477-b8881c12eb0a | 2024-07-10 | Warnings, Adverse reactions | MEROPENEM MEROPENEM |
| Meropenem | MEROPENEM | ARMAS PHARMACEUTICALS INC | e1122310-c3ed-42f1-b189-301c221ff1f0 | 2022-07-29 | Warnings, Adverse reactions | Meropenem MEROPENEM |
| Meropenem | MEROPENEM | WG Critical Care, LLC | 6520ae3d-e149-499c-8152-36f6ab861662 | 2021-06-30 | Warnings, Adverse reactions | Meropenem MEROPENEM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.